Infantile Hemangioma: A Brief Review
- PMID: 26528043
- PMCID: PMC4508608
- DOI: 10.15386/cjmed-381
Infantile Hemangioma: A Brief Review
Abstract
Infantile hemangiomas as frequent infancy tumors have been a controversial issue of medical scientists worldwide. Their clinical aspects are various and their physiopathology is yet to be fully understood. Numerous publications outline the characteristics, causes, evolution possibilities and therapeutic approaches. Deciding whether to treat or not is the main question of this kind of pathology. Hemangiomas that have complications or can cause irreversible damage need therapy. This is a brief review of up-to-date information regarding the presentation of infantile hemangiomas and target-therapies.
Keywords: etiopathogenesis; infantile hemangiomas; therapy.
Figures
Similar articles
-
Infantile hemangiomas: what have we learned from propranolol?Curr Opin Pediatr. 2018 Aug;30(4):499-504. doi: 10.1097/MOP.0000000000000650. Curr Opin Pediatr. 2018. PMID: 29846253 Review.
-
Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma.Arch Dermatol. 2001 Dec;137(12):1607-20. doi: 10.1001/archderm.137.12.1607. Arch Dermatol. 2001. PMID: 11735711
-
Growth characteristics of infantile hemangiomas: implications for management.Pediatrics. 2008 Aug;122(2):360-7. doi: 10.1542/peds.2007-2767. Pediatrics. 2008. PMID: 18676554
-
Subglottic hemangioma: Understanding the association with facial segmental hemangioma in a beard distribution.Int J Pediatr Otorhinolaryngol. 2018 Oct;113:34-37. doi: 10.1016/j.ijporl.2018.07.019. Epub 2018 Jul 12. Int J Pediatr Otorhinolaryngol. 2018. PMID: 30174006
-
Infantile Hemangiomas in the Head and Neck Region.Otolaryngol Clin North Am. 2018 Feb;51(1):77-87. doi: 10.1016/j.otc.2017.09.009. Otolaryngol Clin North Am. 2018. PMID: 29217069 Review.
Cited by
-
Rare complication - skin atrophy - after systemic conservative therapy of infantile hemangioma.BMC Pediatr. 2024 Feb 23;24(1):138. doi: 10.1186/s12887-024-04638-w. BMC Pediatr. 2024. PMID: 38395819 Free PMC article.
-
Neonatal vascular anomalies manifesting as soft-tissue masses.Pediatr Radiol. 2022 Apr;52(4):786-801. doi: 10.1007/s00247-021-05149-x. Epub 2021 Aug 10. Pediatr Radiol. 2022. PMID: 34374837 Review.
-
The Genetic Architecture of Vascular Anomalies: Current Data and Future Therapeutic Perspectives Correlated with Molecular Mechanisms.Int J Mol Sci. 2022 Oct 13;23(20):12199. doi: 10.3390/ijms232012199. Int J Mol Sci. 2022. PMID: 36293054 Free PMC article. Review.
-
Propranolol vs. steroids in the treatment of infantile hemangiomas: A meta-analysis.Mol Clin Oncol. 2021 Aug;15(2):156. doi: 10.3892/mco.2021.2318. Epub 2021 Jun 10. Mol Clin Oncol. 2021. PMID: 34178327 Free PMC article.
-
Association of ATF4 Expression With Tissue Hypoxia and M2 Macrophage Infiltration in Infantile Hemangioma.J Histochem Cytochem. 2017 May;65(5):285-294. doi: 10.1369/0022155417694872. Epub 2017 Feb 1. J Histochem Cytochem. 2017. PMID: 28438094 Free PMC article.
References
-
- Ma X, Zhao T, Xiao Y, Yu J, Chen H, Huang Y, et al. Preliminary experience on treatment of infantile hemangioma with low-dose propranolol in China. Eur J Pediatr. 2013;172(5):653–659. - PubMed
-
- Weston WL, Lane AT, Morelli JG. Lesiones vasculares. In: Weston WL, Lane AT, Morelli JG, editors. Dermatologia pediatrica. 4ed. Spain: Elsevier; 2008. pp. 237–255.
-
- Lucky AW. Lesiones cutaneas benignas transitorias en el recien nacido. In: Eichenfield LF, Frieden IJ, Esterly NB, editors. Dermatologia neonatal. 2ed. Spain: Elsevier; 2009. pp. 85–97.
-
- Drolet BA, Swanson EA, Frieden IJ, Hemangioma Investigator Group Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr. 2008;153(5):712–715. 715.e1. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources